Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial
Palabras clave :
Cholinergic urticaria
Omalizumab
Clinical trial
Exercise
Exercise challenge test
Cholinergic urticaria
UCOL score
Fecha de publicación :
2019
Cita:
Gastaminza, G. (Gabriel); Azofra, J. (Julián); Nuñez-Cordoba, J.M. (Jorge M.); et al. "Efficacy and safety of Omalizumab (Xolair) for cholinergic urticaria in patients unresponsive to a double dose of antihistamines: A randomized mixed double-blind and open-label placebo-controlled clinical trial". The Journal of Allergy and Clinical Immunology: In Practice. 7 (5), 2019, 1599 - 1609
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.